SCHEMBL3846926

SCHEMBL3846926

Cc1ccnc(NC(=O)c2ccc(-c3cnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cn34)cc2Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 3/20 0.42
ATM Q13315 1/20 0.38
DYRK1A Q13627 1/20 0.38
LMNA P02545 1/20 0.38
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
EPHB3 P54753 1/20 0.37
MKNK1 Q9BUB5 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
CLK1 P49759 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845025 0.91 SORT1 (0.41) SORT1ATMDYRK1ALMNANPC1
SCHEMBL3848378 0.86 EPHB3 (0.38) DYRK1ANPC1RAB9ASMN1; SMN2EPHB3
SCHEMBL3845296 0.84 EPHB3 (0.38) NPC1RAB9ASMN1; SMN2EPHB3MKNK1
SCHEMBL3849103 0.82 EPHB3 (0.40) LMNANPC1RAB9AKMT2APOLB
SCHEMBL3845229 0.80 SMN1; SMN2 (0.46) SORT1NPC1RAB9AKMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL4715592 0.80 SORT1 (0.43) SORT1KMT2ACLK1
SCHEMBL3845914 0.79 MAPK1 (0.42) DYRK1ANPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL3846174 0.78 EPHB3 (0.39) SMN1; SMN2EPHB3MKNK1MKNK2CLK1
SCHEMBL3847111 0.77 CLK1 (0.41) DYRK1AMKNK1MKNK2CLK1
SCHEMBL3846730 0.76 IDO1 (0.40) CLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed